Delic Completes Offerings of Debentures

July 29, 2022

Delic Holdings Corp a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022

Delic 2021 Revenue Shows Strong Growth as Nation’s Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services

July 21, 2022

Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon

Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year

July 20, 2022

The Cannabis Scientist Power List is an annual recognition of the most important innovators within the cannabis industry. Dr. Roggen has been named to the list for the third consecutive year.

Ketamine Wellness Centers (KWC) Launches Ketamine Wellness Integrative Therapist Directory

June 30, 2022

Nation’s Largest Ketamine Therapy Provider Offers Complimentary Patient Resource Supporting Holistic Mental Health Treatment

Delic Corp to Present Vision for Long-Term Growth and Industry-Leading Clinic Developments at First Annual H.C. Wainwright Mental Health Conference

June 23, 2022

Matt Stang, CEO and Co-Founder of Delic Corp, will discuss the company’s strategic outlook for the remainder of the year and the latest developments at the nation’s largest ketamine provider, Ketamine Wellness Centers (KWC)

Delic Labs to Present on Psychedelics, Cannabis Extraction at Grow Up Conference and Expo

June 16, 2022

Dr. Markus Roggen, President and Chief Scientific Officer of Delic Labs, will discuss the advancement of psychedelics as well as improvements of cannabis extraction technology during the Grow Up Conference and Expo in Victoria, British Columbia on Ju

Ketamine Wellness Centers (KWC) Launches SPRAVATO® Nasal Spray Therapy in Minneapolis, Salt Lake City and Dallas

June 1, 2022

Largest Ketamine Provider in the U.S. Now Offering FDA-Approved Esketamine Nasal Spray Offering for Adults in Six Cities

Delic Holdings Corp Announces Filings of Annual Documents

May 31, 2022

Delic Corp has filed its annual financial statements, management’s discussion and analysis, and related certifications for the year ended December 31, 2021

Delic Corp to Present on Company’s Expansion Strategy, Industry Outlook at H.C. Wainwright Conference

May 18, 2022

Matt Stang, Co-founder and CEO of Delic Corp, will share the Company’s strategic targets for the remainder of the year at the H.C. Wainwright Annual Global Life Sciences Conference from May 23-26

Delic Holdings Corp Provides Default Status Update

May 16, 2022

Delic Corp is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.

Delic Corp uses cookies to
ensure you get the best experience
on our website. View our Privacy
Policy for more information.